Stay updated on Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial

Sign up to get notified when there's something new on the Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.3 to v3.5.4 on the page, reflecting a version update of the page template rather than changes to the study details. No study content appears to be altered.
    Difference
    0.1%
    Check dated 2026-05-15T15:54:34.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    The page footer/version indicator has been updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a site release rather than a change to the underlying study details.
    Difference
    0.1%
    Check dated 2026-04-24T05:43:09.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:20:34.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T03:28:00.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Footer Revision updated from v3.4.2 to v3.4.3; no changes to study content or data.
    Difference
    0.1%
    Check dated 2026-03-11T20:07:24.000Z thumbnail image
  9. Check
    111 days ago
    Change Detected
    Summary
    Addition of Revision: v3.4.2 and removal of the government funding status notice appear to be site housekeeping; no changes to the study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T05:43:33.000Z thumbnail image

Stay in the know with updates to Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial page.